Smith, C. V., Hansen, T. N., Martin, N. E., McMicken, H. W. & Elliott, S. J. Oxidant stress responses in premature infants during exposure to hyperoxia. Pediatr. Res. 34, 360–365 (1993).

Article  CAS  PubMed  Google Scholar 

Rajendran, P. et al. Antioxidants and human diseases. Clin. Chim. Acta 436, 332–347 (2014).

Article  CAS  PubMed  Google Scholar 

Arnér, E. S. & Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267, 6102–6109 (2000).

Article  PubMed  Google Scholar 

Asikainen, T. M. & White, C. W. Antioxidant defenses in the preterm lung: role for hypoxia-inducible factors in BPD? Toxicol. Appl Pharm. 203, 177–188 (2005).

Article  CAS  Google Scholar 

Lu, J. & Holmgren, A. The thioredoxin antioxidant system. Free Radic. Biol. Med. 66, 75–87 (2014).

Article  CAS  PubMed  Google Scholar 

Muri, J. & Kopf, M. The thioredoxin system: Balancing redox responses in immune cells and tumors. Eur. J. Immunol. 53, e2249948 (2023).

Article  PubMed  Google Scholar 

Oberacker, T., Kraft, L., Schanz, M., Latus, J. & Schricker, S. The importance of thioredoxin-1 in health and disease. Antioxid. (Basel) 12, 1078 (2023).

Article  CAS  Google Scholar 

Holmgren, A. Thioredoxin and glutaredoxin systems. J. Biol. Chem. 264, 13963–13966 (1989).

Article  CAS  PubMed  Google Scholar 

Bertini, R. et al. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J. Exp. Med. 189, 1783–1789 (1999).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shan, R. et al. Effects of hyperoxia on cytoplasmic thioredoxin system in alveolar type epithelial cells of premature rats. J. Huazhong Univ. Sci. Technol. Med. Sci. 31, 258–263 (2011).

Article  CAS  Google Scholar 

Nakamura, H., Hoshino, Y., Okuyama, H., Matsuo, Y. & Yodoi, J. Thioredoxin 1 delivery as new therapeutics. Adv. Drug Deliv. Rev. 61, 303–309 (2009).

Article  CAS  PubMed  Google Scholar 

Chen, Y. et al. Thioredoxin protects fetal type II epithelial cells from hyperoxia-induced injury. Pediatr. Pulmonol. 45, 1192–1200 (2010).

Article  PubMed  Google Scholar 

Nagano, N. et al. Attenuation of hyperoxic lung injury in newborn thioredoxin-1-overexpressing mice through the suppression of proinflammatory cytokine mRNA expression. Biomedicines 8, 66 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamada, T. et al. Thioredoxin-1 protects against hyperoxia-induced apoptosis in cells of the alveolar walls. Pulm. Pharm. Ther. 20, 650–659 (2007).

Article  CAS  Google Scholar 

Das, K. C. Thioredoxin-deficient mice, a novel phenotype sensitive to ambient air and hypersensitive to hyperoxia-induced lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 308, L429–L442 (2015).

Article  CAS  PubMed  Google Scholar 

Namba, F. et al. Human thioredoxin-1 attenuates the rate of lipopolysaccharide-induced preterm delivery in mice in association with its anti-inflammatory effect. Pediatr. Res. 80, 433–439 (2016).

Article  CAS  PubMed  Google Scholar 

Tanabe, N. et al. Thioredoxin-1 protects against neutrophilic inflammation and emphysema progression in a mouse model of chronic obstructive pulmonary disease exacerbation. PLoS One 8, e79016 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian, H. et al. Thioredoxin ameliorates cutaneous inflammation by regulating the epithelial production and release of pro-inflammatory cytokines. Front Immunol. 4, 269 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Yamada, Y. et al. Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma. Immunol. Lett. 86, 199–205 (2003).

Article  CAS  PubMed  Google Scholar 

Hofer, S. et al. Thioredoxin in human and experimental sepsis. Crit. Care Med. 37, 2155–2159 (2009).

Article  CAS  PubMed  Google Scholar 

Callister, M. E. et al. Extracellular thioredoxin levels are increased in patients with acute lung injury. Thorax 61, 521–527 (2006).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu, T. et al. Prognostic value of serum thioredoxin levels in ischemic stroke. Neurol. Res. 39, 988–995 (2017).

Article  CAS  PubMed  Google Scholar 

Wu, Y., Yang, L. & Zhong, L. Decreased serum levels of thioredoxin in patients with coronary artery disease plus hyperhomocysteinemia is strongly associated with the disease severity. Atherosclerosis 212, 351–355 (2010).

Article  CAS  PubMed  Google Scholar 

Bhandari, A. & Bhandari, V. Biomarkers in bronchopulmonary dysplasia. Paediatr. Respir. Rev. 14, 173–179 (2013).

PubMed  Google Scholar 

Piersigilli, F. et al. Identification of new biomarkers of bronchopulmonary dysplasia using metabolomics. Metabolomics 15, 20 (2019).

Article  CAS  PubMed  Google Scholar 

Tipple, T. E., Welty, S. E., Nelin, L. D., Hansen, J. M. & Rogers, L. K. Alterations of the thioredoxin system by hyperoxia: implications for alveolar development. Am. J. Respir. Cell Mol. Biol. 41, 612–619 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lundberg, M. et al. Methodological aspects of ELISA analysis of thioredoxin 1 in human plasma and cerebrospinal fluid. PLoS One 9, e103554 (2014).

Article  PubMed  PubMed Central  Google Scholar